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Background: Hyperglycemia could induce oxidative stress, activate transcription factor nuclear factor kappa B
(NF-κB), up-regulate expression of endothelial adhesion molecules, and lead to endothelial injury. Studies have
indicated that propofol could attenuate oxidative stress and suppress NF-κB activation in some situations. In the
present study, we examined whether and how propofol improved high glucose-induced up-regulation of
endothelial adhesion molecules in human umbilical vein endothelial cells (HUVECs).
Methods: Protein expression of endothelial adhesion molecules, NF-κB, inhibitory subunit of NF-κBα (IκBα),
protein kinase Cβ2 (PKCβ2), and phosphorylation of PKCβ2 (Ser660) were measured by Western blot. NF-κB activity
was measured by electrophoretic mobility shift assay. PKC activity was measured with SignaTECT PKC assay system.
Superoxide anion (O2
.-) accumulation was measured with the reduction of ferricytochrome c assay. Human
peripheral mononuclear cells were prepared with Histopaque-1077 solution.
Results: High glucose induced the expression of endothelial selectin (E-selectin), intercellular adhesion molecule 1
(ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and increased mononuclear-endothelial adhesion. High
glucose induced O2
.- accumulation, PKCβ2 phosphorylation and PKC activation. Further, high glucose decreased IκBα
expression in cytoplasm, increased the translocation of NF-κB from cytoplasm to nuclear, and induced NF-κB
activation. Importantly, we found these high glucose-mediated effects were attenuated by propofol pretreatment.
Moreover, CGP53353, a selective PKCβ2 inhibitor, decreased high glucose-induced NF-κB activation, adhesion
molecules expression, and mononuclear-endothelial adhesion.
Conclusion: Propofol, via decreasing O2
.- accumulation, down-regulating PKCβ2 Ser660 phosphorylation and PKC as
well as NF-κB activity, attenuated high glucose-induced endothelial adhesion molecules expression and
mononuclear-endothelial adhesion.
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Perioperative hyperglycemia, a metabolic alteration caused
by perioperative physiological stress and excessive glucose
infusion, was commonly seen in non-diabetics [1] as well
as diabetics [2]. Hyperglycemia could up-regulate the
expression of endothelial adhesion molecules, such as en-
dothelial selectin (E-selectin), intercellular adhesion mol-
ecule 1 (ICAM-1), and vascular cell adhesion molecule 1* Correspondence: 09211230020@fudan.edu.com
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reproduction in any medium, provided the or(VCAM-1) [3-5], thus augmenting pathological leukocytes-
endothelial adhesion [3] and leading to endothelial dys-
function and injury. Accordingly, during perioperative
period, especially for hyperglycemic patients, interventions
that may inhibit endothelial adhesion molecules expres-
sion are potential strategies to protect endothelial cells
from dysfunction and its sequelae.
Hyperglycemia could induce overproduction of react-
ive oxygen species (ROS), which is one of the major fac-
tors responsible for diabetic vascular injury [6,7]. The
nuclear factor kappa B (NF-κB) signal pathway was also
reported to be involved in high glucose-induced up-. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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et al. and Kwon et al. reported that high glucose-induced
up-regulation of endothelial adhesion molecules was alle-
viated by inhibiting ROS generation and NF-κB activity
[8,9]. Propofol (2, 6-diisopropylphenol) is a widely used
intravenous anesthetic agent. Chen J et al. found propofol
could suppress oxidative stress, NF-κB activation and
mononuclear-endothelial adhesion in endothelial cells
exposed to hydrogen peroxide [10]. However, the protect-
ive effects of propofol on hyperglycemia-induced expres-
sion of endothelial adhesion molecules have not been well
studied. In the present study, we examined whether propo-
fol improved high glucose-induced up-regulation of endo-
thelial adhesion molecules and mononuclear-endothelial
adhesion in human umbilical vein endothelial cells
(HUVECs). More importantly, we explored the potential
underlying mechanisms.Methods
Cell culture
HUVECs (Clonetics) were grown in Dulbecco’s modified
Eagle medium (DMEM) with 5 mM glucose and 10% fetal
bovine serum. Cells were cultured in an incubator supple-
mented with 5% CO2-95% air at 37°C and sub-cultured on
reaching 90% confluence. The fourth passage of cells was
employed in this study.Study design
HUVECs were cultured with different concentrations (5,
10, 15, 20 and 30 mM) of glucose for different times (1, 2, 4
and 8 h). By measuring adhesion molecules expression, we
determined the appropriate glucose treatment conditionFigure 1 Effects of glucose on adhesion molecules expression in hum
cultured in different concentrations of glucose (5, 10, 15, 20, 30 mM) for 4
different times (1, 2, 4, 8 h). (C, D) Quantification of protein band density o
expressed as mean ± SD. ■ represents E-selectin, ░ represents ICAM-1, □ rewith maximal effect on endothelial adhesion molecules ex-
pression. During general anesthesia, plasma concentrations
of propofol range from 5 to 50uM [11]. To mimic in vivo
situations, HUVECs were pre-incubated with different con-
centrations (5, 10, 20, and 40uM) of propofol (Sigma) for
30 min, followed by glucose treatment. The optimal con-
centration of propofol with significant inhibitory effects on
endothelial adhesion molecules expression was determined.
These treatment conditions were used in the subsequent
studies in which HUVECs were cultured and divided into
four groups to examine the underlying signaling pathways.
Group 1: HUVECs were cultured in 5 mM glucose for 4 h
as control; Group 2: HUVECs were pre-incubated with
10uM propofol for 30 min and treated with 5 mM glucose
for 4 h; Group 3: HUVECs were treated with 15 mM glu-
cose for 4 h; Group 4: HUVECs were pre-incubated with
10uM propofol for 30 min and treated with 15 mM glucose
for 4 h.Western blot analysis
Whole-cell extracts, nuclear extracts and cytoplasmic
extracts were prepared with the use of Nuclear Extract Kit
(Active Motif) according to the manufacturer’s instruc-
tions. Equal amounts of protein were separated by 6% or
8% SDS-PAGE and transferred to PVDF membranes.
After being blocked in 5% skim milk, the membranes were
incubated with an appropriate dilution of primary anti-
body at 4°C for overnight. The primary antibodies were
monoclonal antibody against E-selectin (Santa Cruz
Biotechnology), protein kinase Cβ2 (PKCβ2) (Abcam),
Phospho-PKCβ2(ser660)( Abcam), β-actin (Santa Cruz
Biotechnology), and polyclonal antibody against ICAM-1an umbilical vein endothelial cells (HUVECs). (A) HUVECs were
hours. (B) HUVECs were cultured in 5 mM or 15 mM glucose for
f adhesion molecules (*p < 0.05 vs. 5 mM glucose, n = 5). Data were
presents VCAM-1.
Figure 2 Effects of propofol on adhesion molecules expression in hyperglycemic human umbilical vein endothelial cells (HUVECs).
(A) HUVECs were pre-incubated with different concentrations (5, 10, 20, and 40uM) of propofol for 30 min, followed by glucose treatment.
(B) Quantification of protein band density of adhesion molecules (*p < 0.05 vs. 5 mM glucose, #p < 0.05 vs. 15 mM glucose, n = 5). (C) HUVECs
were pre-incubated with 10uM propofol for 30 min, followed by 5 mM glucose treatment. (D) Quantification of protein band density of adhesion
molecules (*p < 0.05 vs. 5 mM glucose, #p < 0.05 vs. 15 mM glucose, n = 5). Data were expressed as mean ± SD. ■ represents E-selectin,
░ represents ICAM-1, □ represents VCAM-1.
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technology), NF-κB p65 (Cell Signaling Technology), in-
hibitory subunit of nuclear factor-κBα (IκBα) (Santa Cruz
Biotechnology), Histone H3 (Santa Cruz Biotechnology).
Then, the membranes were incubated with secondary
antibody, washed, and detected with the ECL system. The
relative densities of protein bands were analyzed by Scan-
gel-it software.PKC activity assay
PKC activity was measured with SignaTECT PKC assay
system (Promega) according to the manufacturer’s instruc-
tions. In brief, membrane extracts, reaction buffer
(100 mM Tris–HCl, 1.6 mg/ml phosphatidylserine,
0.16 mg/ml diacylglycerol, 50 mM MgCl2) and [γ-32P]
ATP were mixed and kept at 30°C for 10 min. PKC phos-
phorylation was determined by measuring the radioactivity.
Figure 3 Effects of propofol on 15 mM glucose-mediated nuclear factor kappa B (NF-κB) signal pathway. (A) Human umbilical vein
endothelial cells were cultured in either 5 mM glucose or 15 mM glucose for 4 h with corresponding treatment. (B) Quantification of protein band
density of NF-κB (p65) (*p < 0.05 vs. 5 mM glucose, #p < 0.05 vs. 15 mM glucose, n = 5). ■ represents nuclear extract, □ represents cytoplasmic extract.
(C) Quantification of protein band density of IκBα (*p < 0.05 vs. 5 mM glucose, #p < 0.05 vs. 15 mM glucose, n = 5). Data were shown as mean ± SD.
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ing the activity of the enzyme in the absence of phospholi-
pids from that of the enzyme in the presence of
phospholipids. The results were shown as folds increased
compared with 5 mM glucose group.
Electrophoretic mobility shift assay
NF-κB activity was measured by electrophoretic mobility
shift assay as described previously [10]. In brief, [γ-32P]
ATP (Amersham Life Sciences) was used to end-label the
complementary oligonucleotides containing NF-κB binding
site (5’-TGTCGAATGCAAATCACTAGAA-3’), and QIA-
quick Nucleotide Removal Kit (Qiagene) was use to elimin-
ate the unincorporated [γ-32P] ATP. The radiolabeledprobes and nuclear extracts were incubated together for
30 min. For supershift assay, 5 μg rabbit polyclonal antibody
against NF-κB (Santa Cruz Biotechnology) was mixed with
nuclear extracts on ice for 1 h before the addition of radiola-
beled probes. The specificity was verified by supershift assay
with 5 μg normal rabbit IgG (Santa Cruz Biotechnology).
For competition assay, 100-fold excess of nonradiolabeled
probes were incubated with nuclear extracts for 10 min
before the addition of radiolabeled probes. As negative
control for competition assay, 100-fold excess of nonra-
diolabeled probes containing a mutant NF-κB binding site
(5’-TGTCGAATGCAAGCCACTAG AA-3’) were used as
competitors. The DNA-protein complexes were separated
by electrophoresis in a 6% non-denaturing polyacrylamide
Figure 4 Effects of propofol on 15 mM glucose-induced nuclear factor kappa B (NF-κB) activation. (A) Human umbilical vein endothelial
cells were cultured in either 5 mM glucose or 15 mM glucose for 4 h with corresponding treatment. Shifted band was increased by 15 mM
glucose, but reduced by propofol (n = 5). (B) In the supershift assay, 15 mM glucose-induced band was shifted by the pre-incubation of nuclear
extracts with anti-NF-κB antibody, but was not affected by normal rabbit IgG (n = 5). (C) In the competition assay, 100-fold excess of
nonradiolabeled probes were incubated with nuclear extracts 10 min before the addition of radiolabeled probes. 15 mM glucose-induced shifted
band was blocked by nonradiolabeled competitors, but mutant competitors had no such effect (n = 5).
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Figure 5 Effects of propofol on 15 mM glucose-induced Ser660 phosphorylation of protein kinase Cβ2 (PKCβ2) and PKC activation.
(A) Human umbilical vein endothelial cells (HUVECs) were cultured in either 5 mM glucose or 15 mM glucose for 4 h with corresponding
treatment. (B) Quantification of protein band density of PKCβ2 or phosphorylated PKCβ2 (*p < 0.05 vs. 5 mM glucose, #p < 0.05 vs. 15 mM
glucose, n = 5). ■ represents PKCβ2 phosphorylation, □ represents PKCβ2. (C) HUVECs were cultured in either 5 mM glucose or 15 mM glucose
for 4 h with corresponding treatment. (*p < 0.05 vs. 5 mM glucose, #p < 0.05 vs. 15 mM glucose, n = 5). The results were shown as folds increased
compared with 5 mM glucose group.
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Figure 6 Effects of propofol on 15 mM glucose-induced
superoxide anion (O2
.-) accumulation. Human umbilical vein
endothelial cells were cultured in either 5 mM glucose or 15 mM
glucose for 4 h with corresponding treatment. (*p < 0.05 vs. 5 mM
glucose, #p < 0.05 vs. 15 mM glucose, n = 5). Data were shown as
mean ± SD. (a.u. = arbitrary units).
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graphic film for 24 h at −80°C.
Superoxide anion (O2
.- ) accumulation assay
O2
.- accumulation was measured by the reduction of
ferricytochrome c assay as described previously [12].
Briefly, HUVECs were washed and cultured with Krebs-
HEPES buffer containing 20 μM ferricytochrome c
(Sigma) with or without superoxide dismutase (Sigma).
The absorbance was read spectrophotometrically at
550 nm. Reduction of ferricytochrome c with super-
oxide dismutase was subtracted from the values without
superoxide dismutase.
Isolation and adhesion of mononuclear cells to HUVECs
The isolation of human peripheral mononuclear cells was
prepared with the use of Histopaque-1077 (Sigma). In
brief, 5 ml heparinized blood from healthy volunteers was
carefully layered onto 5 ml Histopaque-1077. The mono-
nuclear cells were collected after the blood was centri-
fuged at 400 g for 30 min. Isolated mononuclear cells
were then washed twice with PBS, suspended in the cul-
ture medium, and added to the HUVECs . After incuba-
tion at 37°C for 30 min, cells were washed three times
with PBS, and observed under a phase-contrast micro-
scope. Adherent cells were counted in 10 different fields
from three separate culture dishes. Written informedconsent was obtained from the volunteers for publication
of this report and any accompanying images.
Statistical analysis
Data were expressed as mean ± SD, and n indicates num-
ber of experiments. Statistical significance was determined
in multiple comparisons among independent groups of
data in which analysis of variance indicated the presence
of significant difference. A value of p < 0.05 was considered
significant.
Results
15 mM glucose-induced endothelial adhesion molecules
expression and its modulation by propofol
In HUVECs, compared with 5 mM glucose treatment, high
concentrations of glucose caused a marked up-regulation of
adhesion molecules expression in a concentration- and
time-dependent manner. Incubation of cells with 15 mM
glucose for 4 h caused a significant up-regulation of E-
selectin, ICAM-1 and VCAM-1 expression (Figure 1). We
also found that propofol pre-treatment could attenuate
15 mM glucose-induced adhesion molecules expression in a
concentration-dependent manner. Compared with 15 mM
glucose treatment, pre-incubation of cells with 10uM pro-
pofol for 30 min significantly attenuated 15 mM glucose-
induced adhesion molecules expression (Figure 2A, B).
Propofol solvent dimethyl sulfoxide (DMSO) did not affect
15 mM glucose-induced adhesion molecules expression
(Figure 2A, B).
Please note pre-incubation of cells with 10uM propo-
fol for 30 min had no effect on endothelial adhesion
molecules expression in cells cultured in 5 mM glucose
(Figure 2C, D).
15 mM glucose-induced NF-κB, PKC and PKCβ2 activation
and its modulation by propofol
In HUVECs, compared with 5 mM glucose treatment,
15 mM glucose increased the expression of NF-κB p65
protein in the nuclear extracts and decreased its expres-
sion in the cytoplasmic extracts (Figure 3A, B), and these
effects were alleviated by propofol pre-treatment. Consist-
ently, compared with 5 mM glucose treatment, 15 mM glu-
cose deceased IκBα expression in the cytoplasmic extracts
(Figure 3A, C), which was also recovered by propofol pre-
treatment (Figure 3A, C). The effect of 15 mM glucose and
propofol on NF-κB activity was determined by electrophor-
etic mobility shift assay. We found 15 mM glucose induced
NF-κB activation, which was attenuated by propofol pre-
treatment (Figure 4A). The specificity was confirmed by
supershift assay and competition assay (Figure 4B, C).
Compared with 5 mM glucose treatment, 15 mM glu-
cose increased Ser660 phosphorylation of PKCβ2, which
was attenuated by propofol. However, compared with
5 mM glucose, 15 mM glucose and propofol had no effect
Figure 7 Effects of propofol and CGP53353 on 15 mM glucose-induced nuclear factor kappa B (NF-κB) activation. (A) Human umbilical
vein endothelial cells (HUVECs) were cultured in either 5 mM glucose or 15 mM glucose for 4 h with corresponding treatment. (B) Quantification
of protein band density of NF-κB (p65) (*p < 0.05 vs. 5 mM glucose, #p < 0.05 vs. 15 mM glucose, n = 5). Data were shown as mean ± SD.
(C) HUVECs were cultured in either 5 mM glucose or 15 mM glucose for 4 h with corresponding treatment. Shifted band was increased by
15 mM glucose, but reduced by propofol or CGP53353 (n = 5).
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with 5 mM glucose treatment, 15 mM glucose induced
marked PKC activation, which was attenuated by propofol
(Figure 5C).15 mM glucose-induced O2
.- accumulation and its
modulation by propofol
Compared with 5 mM glucose treatment, 15 mM glucose
induced a significant increase of O2
.- accumulation. More
importantly, we found that propofol could mitigate 15 mM
glucose-induced O2
.- accumulation (Figure 6).15 mM glucose-induced endothelial dysfunction and its
modulation by propofol and PKCβ2 inhibitor
CGP53353, a highly selective inhibitor of PKCβ2, could
decrease 15 mM glucose-induced expression of NF-κB
p65 protein in the nuclear extracts (Figure 7A, B), and
the effect was similar to that of propofol. We also found
that 15 mM glucose-induced NF-κB activation was atte-
nuated by CGP53353 (Figure 7C).
In addition, CGP53353 and propofol decreased 15 mM
glucose-induced expression of adhesion molecules to a
similar extent (Figure 8). Consistently, 15 mM glucose
greatly induced mononuclear-endothelial adhesion, which
Figure 8 Effects of propofol and CGP53353 on 15 mM glucose-induced adhesion molecule expression. (A) Human umbilical vein
endothelial cells were cultured in either 5 mM glucose or 15 mM glucose for 4 h with corresponding treatment. (B) Quantification of protein
band density of adhesion molecules (*p < 0.05 vs. 5 mM glucose, #p < 0.05 vs. 15 mM glucose, n = 5). Data were shown as mean ± SD.
■ represents E-selectin, ░ represents ICAM-1, □ represents VCAM-1.
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(Figure 9).
Discussion
The main finding of the present study is that propofol
could protect HUVECs against 15 mM glucose-induced
endothelial adhesion molecules expression and mononuclear-
endothelial interaction. Our data also suggested that the
protective effects of propofol might be achieved by attenu-
ating O2
.- accumulation, inhibiting PKCβ2 ser660 phosphor-
ylation, PKC activity and NF-κB activation.
Hyperglycemia could up-regulate endothelial adhesion
molecules expression, thus leading to the adhesion of
monocytes to endothelial cells [3-5]. Many studies indi-
cated that NF-κB signal pathway was involved in the
hyperglycemia-mediated up-regulation of gene and protein
expression of endothelial adhesion molecules, including
VCAM-1, ICAM-1, and E-selectin [3-5,13-16]. Thesefindings were consistent with our study (Figures 1, 2, 3, 4).
Further, we suggested that PKCβ2 was involved in this
process and its activation laid up-stream of NF-κB activa-
tion (Figure 5, 7, 8, 9). This was consistent with a previous
study, which demonstrated that PKCβ2 and NF-κB played
a key role in high glucose-mediated up-regulation of
VCAM-1 in vascular endothelial cells [17]. However, other
pathways were also claimed to be responsible. Kim S et al.
reported that high glucose-induced endothelial adhesion
molecules expression was mediated through the p38
mitogen-activated protein kinase (MAPK) signaling path-
way [18]. In our preliminary experiments, we examined
the activity of p38 MAPK, but did not detect its activation
in response to 15 mM glucose (data not shown). We
noticed that endothelial cells were treated with 25 mM
glucose for 24 h in their study, while we treated endothe-
lial cells with 15 mM glucose for 4 h. One potential ex-
planation for the discrepancy between their findings and
Figure 9 15mM glucose-induced mononuclear-endothelial
adhesion and its modulation by propofol and CGP53353.
Compared with 5 mM glucose, 15 mM glucose greatly induced
mononuclear-endothelial adhesion, which was ameliorated by
propofol or CGP53353 pretreatment (*p < 0.05 vs. 5 mM glucose,
#p < 0.05 vs. 15 mM glucose, n = 5). Data were shown as mean ± SD.
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treatment may up-regulate the expression of endothelial
adhesion molecules through different pathways.
The necessity to regulate plasma glucose concentration
to normal levels in perioperative hyperglycemic patients is
debatable, because it may cause severe hypoglycemia and
other serious adverse events [19]. As such, scientists are
devoting to explore novel strategies, which may exert
beneficial effects without tightly regulating plasma glucose
levels. Recently, endothelial adhesion molecules have been
widely considered to be potential targets for the effective
treatment of high glucose-induced endothelial injury [20].
It has been shown that high glucose-induced mono-
nuclear-endothelial cell adhesion and endothelial injury
can be attenuated by several compounds, such as fasudil
[21] and cannabidiol [22]. Interestingly, these compounds
have the property to reduce superoxide generation and de-
crease endothelial adhesion molecules expression [21,22].
So, antioxidant may be a novel vascular protective strategy
for hyperglycemic patients.
Propofol is an intravenous anesthetic agent which is
widely used in clinical settings. Besides anesthetic proper-
ties, other characteristics of propofol have been widely
studied in recent years. Propofol is chemically similar to
endogenous antioxidant a-tocopheral (Vitamin E), and the-
oretically it should demonstrate similar properties [23].
Chen J et al. reported that propofol could attenuate the ad-
hesion of monocytes to oxidative stress-activated HUVECs
[10]. This was quite consistent with ours. In the presentstudy, we found that propofol could significantly alleviate
15 mM glucose-induced O2
.- accumulation (Figure 6),
endothelial adhesion molecules expression (Figure 2) and
mononuclear-endothelial cell interaction (Figure 9). So we
believe the antioxidative property of propofol is one of the
main mechanisms for its protective effects on HUVECs.
The activation of NF-κB consists of several steps, starting
with the degradation of IκB, a cytoplasmic inhibitor of NF-
κB [24]. Among IκB family, IκBα is the most widely studied
[25]. IκBα degradation leads to the translocation of NF-κB
from the cytoplasm compartment to the nuclear, where it
could recognize and bind to the promoter of target genes
and regulate the expression of these genes [26]. Studies have
indicated that propofol could inhibit NF-κB activation in
endothelial cells exposed to hydrogen peroxide [10] and
lipopolysaccharide [27]. In the present study, we found that
pre-treatment of cells with propofol attenuated 15 mM
glucose-induced cytoplasmic IκBα degradation and NF-κB
translocation (Figure 3). In addition, we demonstrated that
propofol could inhibit 15 mM glucose-induced endothelial
adhesion molecules expression (Figure 2) and mononuclear-
endothelial cell interaction (Figure 9). These results strongly
suggested that the beneficial effects of propofol on 15 mM
glucose-induced endothelial adhesion molecules expres-
sion may result from its inhibitory effects on NF-κB signal
pathway.
It is of interest to determine the leading cause of PKC
activation in response to high glucose. Gallo A et al.,
Gopalakrishna R et al. and Pricci F et al. reported that high
glucose increased oxidative stress, which is responsible for
the translocation and activation of PKC in vascular tissues
[28-30]. It has also been reported that activation of PKCβ2
was associated with high glucose-induced vascular ROS
generation [31] and high glucose-mediated nitric oxide
reduction [32]. In the present study, we found propofol
could attenuate 15 mM glucose-induced O2
.- accumulation
(Figure 6). Consistently, our previous study showed that
propofol could restore high glucose-mediated O2
.- accumu-
lation and nitric oxide reduction via re-coupling endothelial
nitric oxide synthase [33]. Accordingly, we suggested that
the antioxidative effect of propofol is a potential mechanism
responsible for the beneficial effect on high glucose-
mediated PKC activation and mononuclear-endothelial
adhesion.
In a recent study, vascular healing responses were
described after drug-eluting stent implantation in experi-
mental models, employing everolimus or paclitaxel [34]. In
these models, anesthesia was achieved with propofol. We
may raise the assumption that the obtained favorable
effects were at least partially due to propofol. Further stud-
ies in in vivo models are necessary to verify this hypothesis.
This study has some limitations. First, the study was car-
ried out in HUVECs, which is an in vitro system. It differs
from in vivo settings, especially when drug effectiveness
Zhu et al. Cardiovascular Diabetology 2013, 12:13 Page 11 of 12
http://www.cardiab.com/content/12/1/13and toxicity is considered. Secondly, we did not investigate
the effect of propofol and high glucose on mononuclear.
So further experiments are required to determine whether
the effect of propofol on high glucose-induced mono-
nuclear-endothelial interaction is mediated by endothelial
cells, mononuclear cells, or both.
Conclusions
In summary, the present study suggested that 15 mM
glucose, by inducing O2
.- accumulation, PKCβ2 Ser660 phos-
phorylation and PKC activation, NF-κB activation, up-
regulated endothelial adhesion molecules expression and
augmented mononuclear-endothelial interaction. More im-
portantly, our study demonstrated that propofol, via de-
creasing O2
.- accumulation, down-regulating PKCβ2 Ser660
phosphorylation and PKC activity, inhibiting NF-κB acti-
vation, attenuated 15 mM glucose-induced endothelial ad-
hesion molecules expression and mononuclear-endothelial
adhesion. Our data implied the potential advantage of the
administration of propofol to provide sedation in hyper-
glycemic patients in operation room or in post anesthesia
care unit.
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